Status:
COMPLETED
Assessment of an App Based on Artificial Intelligence for Purulent AOM Diagnosis in a Pediatric Department
Lead Sponsor:
Fondation Lenval
Conditions:
Otitis Media, Suppurative
Eligibility:
All Genders
Up to 17 years
Phase:
NA
Brief Summary
Otitis media (OM) is one of the most common childhood infections and is a major cause of morbidity in children and results as being the first cause of antibiotic prescription among children in develop...
Detailed Description
Ear infections in children are very common, particularly acute otitis media (AOM) which represents the first reason for visiting physicians and for antibiotic prescription in children in developed cou...
Eligibility Criteria
Inclusion
- Child under 18 years Presenting signs that may suggest acute otitis media (fever, earache, purulent otorrhea) For which the informed written consent of, at least, one of the two parents or the holder of parental authority has been obtained
Exclusion
- A sign (s) of vital distress Trans-tympanic drains
- \-
Key Trial Info
Start Date :
June 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 16 2023
Estimated Enrollment :
203 Patients enrolled
Trial Details
Trial ID
NCT04752891
Start Date
June 10 2021
End Date
March 16 2023
Last Update
March 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpitaux Pédiatrique de Nice CHU Lenval
Nice, France